Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.
NCT00608504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2012-06-05
Summary
The purpose is to study how certain factors, including money, the amount of drug available and the amount of work effort, affect opiate drug choice.
Conditions
- Heroin Dependence
- Opioid-Related Disorders
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Wayne State University
lead OTHER
Principal Investigators
-
Mark Greenwald, PhD · Wayne State University
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
Countries
- United States
Study Locations
More Related Trials
-
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Connected Health to Decrease Opioid Use in Patients With Chronic Pain
NCT04013529 ·Status: COMPLETED ·Phase: NA
-
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
NCT05006079 ·Status: RECRUITING ·Phase: PHASE2
-
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sensory Outcomes in Active Substance Users
NCT06639438 ·Status: RECRUITING
-
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
NCT03958474 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
NCT05591703 ·Status: COMPLETED
-
Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals
NCT01262092 ·Status: COMPLETED ·Phase: PHASE2
-
Epidural Methadone in Healthy Volunteers
NCT03525509 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Health and Employment Outcomes Through Workplace Opioid Policies
NCT05387408 ·Status: COMPLETED ·Phase: NA
-
Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.
NCT01770314 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
NCT03063905 ·Status: TERMINATED
-
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT00490919 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects
NCT01633944 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study
NCT01359930 ·Status: COMPLETED ·Phase: PHASE1
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
NCT05336188 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pharmacogenetics of Naltrexone for Stimulant Abuse
NCT03226223 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
NCT01642030 ·Status: COMPLETED ·Phase: PHASE1